These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6172352

  • 21. Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.
    de Niet A, Jansen L, Zaaijer HL, Klause U, Takkenberg B, Janssen HL, Chu T, Petric R, Reesink HW.
    Antivir Ther; 2014; 19(3):259-67. PubMed ID: 24256626
    [Abstract] [Full Text] [Related]

  • 22. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K, Kocamaz H, Doğan Y.
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.
    Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Luo K, Wang Y, Hadziyannis S, Wolf E, McCloud P, Batrla R, Marcellin P.
    Hepatology; 2009 Apr; 49(4):1141-50. PubMed ID: 19338056
    [Abstract] [Full Text] [Related]

  • 24. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789
    [Abstract] [Full Text] [Related]

  • 25. No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.
    Mücke VT, Mücke MM, Peiffer KH, Weiler N, Welzel TM, Sarrazin C, Zeuzem S, Berger A, Vermehren J.
    Aliment Pharmacol Ther; 2017 Aug 20; 46(4):432-439. PubMed ID: 28627791
    [Abstract] [Full Text] [Related]

  • 26. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
    Moucari R, Korevaar A, Lada O, Martinot-Peignoux M, Boyer N, Mackiewicz V, Dauvergne A, Cardoso AC, Asselah T, Nicolas-Chanoine MH, Vidaud M, Valla D, Bedossa P, Marcellin P.
    J Hepatol; 2009 Jun 20; 50(6):1084-92. PubMed ID: 19376603
    [Abstract] [Full Text] [Related]

  • 27. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH.
    Ann Intern Med; 1991 Apr 15; 114(8):629-34. PubMed ID: 2003708
    [Abstract] [Full Text] [Related]

  • 28. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
    Wooddell CI, Yuen MF, Chan HL, Gish RG, Locarnini SA, Chavez D, Ferrari C, Given BD, Hamilton J, Kanner SB, Lai CL, Lau JYN, Schluep T, Xu Z, Lanford RE, Lewis DL.
    Sci Transl Med; 2017 Sep 27; 9(409):. PubMed ID: 28954926
    [Abstract] [Full Text] [Related]

  • 29. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
    Wiegand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, Michel G, Bock CT, Manns MP, Tillmann HL.
    Antivir Ther; 2008 Sep 27; 13(4):547-54. PubMed ID: 18672533
    [Abstract] [Full Text] [Related]

  • 30. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.
    Han HL, Lang ZW.
    World J Gastroenterol; 2003 Jan 27; 9(1):117-21. PubMed ID: 12508364
    [Abstract] [Full Text] [Related]

  • 31. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb 27; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
    van Nunen AB, Hansen BE, Suh DJ, Löhr HF, Chemello L, Fontaine H, Heathcote J, Song BC, Janssen HL, de Man RA, Schalm SW.
    Gut; 2003 Mar 27; 52(3):420-4. PubMed ID: 12584227
    [Abstract] [Full Text] [Related]

  • 34. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.
    Rijckborst V, Hansen BE, Cakaloglu Y, Ferenci P, Tabak F, Akdogan M, Simon K, Akarca US, Flisiak R, Verhey E, Van Vuuren AJ, Boucher CA, ter Borg MJ, Janssen HL.
    Hepatology; 2010 Aug 27; 52(2):454-61. PubMed ID: 20683945
    [Abstract] [Full Text] [Related]

  • 35. Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir.
    Takkenberg RB, Jansen L, de Niet A, Zaaijer HL, Weegink CJ, Terpstra V, Dijkgraaf MG, Molenkamp R, Jansen PL, Koot M, Rijckborst V, Janssen HL, Beld MG, Reesink HW.
    Antivir Ther; 2013 Aug 27; 18(7):895-904. PubMed ID: 23639931
    [Abstract] [Full Text] [Related]

  • 36. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.
    Pastore G, Dentico P, Angarano G, Lapedota E, Schiraldi O.
    Hepatogastroenterology; 1981 Feb 27; 28(1):20-2. PubMed ID: 7216135
    [Abstract] [Full Text] [Related]

  • 37. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH, Ren XN, Chen LX, Shi BS, Xu CH, Fang Z, Liu X, Chen JL, Zhang XN, Hu YW, Zhou XH.
    World J Gastroenterol; 2015 Mar 28; 21(12):3527-36. PubMed ID: 25834317
    [Abstract] [Full Text] [Related]

  • 38. [Correlation between serum HBV DNA level and HBsAg titer in HBeAg-positive pregnant women and impact of genomic variability of hepatitis B virus pre S/S regions on their correlations].
    Zhang X, Yan L, Lu Y, Wei KP, Liu ZX, Xiao YW, Ding F, Zhuang H, Li J.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug 20; 26(8):579-584. PubMed ID: 30317788
    [Abstract] [Full Text] [Related]

  • 39. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes.
    Tabuchi A, Tanaka J, Katayama K, Mizui M, Matsukura H, Yugi H, Shimada T, Miyakawa Y, Yoshizawa H.
    J Med Virol; 2008 Dec 20; 80(12):2064-8. PubMed ID: 19040280
    [Abstract] [Full Text] [Related]

  • 40. Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B.
    Lee MH, Lee DM, Kim SS, Cheong JY, Cho SW.
    J Med Virol; 2011 Jul 20; 83(7):1178-86. PubMed ID: 21567421
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.